my account  log out
 

Afuco™ Anti-Human DLK1 ADCC Theraputic Antibody (LIV-1205), ADCC Enhanced

Create: 08/09/2019
Expired Date:never
Category: Drugs&Pharmaceutical [Health&Medical&Pharmaceutical]
Message:Anti-DLK1 ADCC Enhanced Antibody (LIV-1205) is an ADCC enhanced antibody produced by our Afuco™ platform. LIV-1205 is a humanized monoclonal antibody targeting cell surface antigen "DLK-1 (Delta-like 1 homolog)" of liver cancer and other solid cancers. DLK-1 is expected to control the proliferation and differentiation of stem cells, progenitor cells, and other immature cells. LIV-1205 have shown potent anti-tumor activity in various cancer models and is expected to have beneficial clinical efficiency. https://www.creativebiolabs.net/Anti-DLK1-ADCC-Enhanced-Antibody-LIV-1205-20509.htm
City:Shirley[US] 
Location:
 
Feb 01 2023 VBS++ (with Ca and Mg) Buffer271
Feb 01 2023 GVBE Buffer279
Feb 01 2023 GVB++ (with Ca and Mg) Buffer279
Feb 01 2023 Hemolysin (Rabbit Anti-Sheep Cell Hemolysin)274
Aug 30 2019Anti-HSV-2 gH Antibody464
Aug 30 2019Anti-L. major LPG Antibody546
Aug 30 2019Anti-DENV-1 Antibody454
Aug 30 2019Anti-BPV-1 L1 Antibody468
Aug 30 2019Anti-H3N2 HA Antibody456
Aug 30 2019Anti-EIAV env Antibody477

return back

Copyright © toextrade Inc. All rights reserved. Contact us